Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3

Blood

Volumn 103, Issue 10, 2004, Pages 3744-3750

  Peltola, Katriina J ^b   Paukku, Kirsi ^b   Aho, Teija L T ^b   Ruuska, Marja ^b   Silvennoinen, Olli ^b   Koskinen, Päivi J ^a  

^a TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; INTERLEUKIN 3; PROLACTIN; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

EID: 2342629177     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3126     Document Type: Article

References (49)

1. Gearing DP, King JA, Gough NM, Nicola NA. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989;8:3667-3676.
2. Polotskaya A, Zhao Y, Lilly M, Kraft A. A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor receptor in mediating cell growth. Cell Growth Differ. 1993;4:523-531.
3. Lilly M, Le T, Holland P, Hendrickson S. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene. 1992;7: 727-732.
4. Quelle F, Sato N, Witthuhn B, et al. JAK2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal domain. Mol Cell Biol. 1994;14:4335-4341.
5. Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995;14:1166-1175.
6. Gouilleux F, Pallard C, Dusanter-Fourt, I, et al. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 1995;14:2005-2013.
7. Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J. 1995;14:2527-2535.
8. de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L. STAT5 activation by Bcr-Abl contributes to transformation of K562 leukemia cells. Blood. 1999;94:1108-1112.
9. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 2002;8:945-954.
10. Onishi M, Nosaka T, Misawa K, et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol. 1998;18:3871-3879.
11. Demoulin JB, Uyttenhove C, Lejeune D, Mui A, Groner B, Renauld JC. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. Cancer Res. 2000;60:3971-3977.
12. Matsumura I, Kitamura T, Wakao H, et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 1999;18: 1367-1377.
13. -/- mice: a direct role for STAT5 in BcI-X(L) induction. Cell. 1999;98:181-191.
14. Matsumoto A, Masuham M, Mitsui K, et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood. 1997;89:3148-3154.
15. Davey HW, McLachlan MJ, Wilkins RJ, Hilton DJ, Adams TE. Stat5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol Cell Endocrinol. 1999;158:111-116.
16. Horvath CM, Darnell JE. The STATe of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol. 1997; 9:233-239.
17. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000;19:2628-2637.
18. Cuypers HT, Selten G, Quint W, et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell. 1984;37:141-150.
19. van Lohuizen M, Verbeek S, Krimpenfort P, et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 1989;58:673-682.
20. Acton D, Domen J, Jacobs H, Vlaar M, Korsmeyer S, Bems A. Collaboration of PIM-1 and BCL-2 in lymphomagenesis. Curr Top Microbiol Immunol. 1992;182:293-298.
21. Saris CJM, Domen J, Bems A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J. 1991;10:655-664.
22. Dautry F, Weil D, Yu J, Dautry-Varsat A. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem. 1988;263:17615-17620.
23. Matikainen S, Saraneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL2-Rα, c-myc, and pim-1 genes in human T cells. Blood. 1999;93:1980-1991.
24. Nieborowska-Skorska M, Hoser G, Kossev P, Wasik MA, Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood. 2002;99:4531-4539.
25. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene. 1999;18:4022-4031.
26. Möröy T, Grzeschiczek A, Petzold S, Hartmann K-U. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc Natl Acad Sci U S A. 1993;90: 10734-10738.
27. Pircher TJ, Zhao S, Geiger JN, Joneja B, Wojchowski DM. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene. 2000;19:3884-3692.
28. Leverson JD, Koskinen PJ, Orrico FC, et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell. 1998;2:417-425.
29. Rainio EM, Sandholm J, Koskinen PJ. Cutting edge: transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. J Immunol. 2002; 168:1524-1527.
30. Hilton DJ, Richardson RT, Alexander WS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A. 1998;95:114-119.
31. Chen XP, Losman JA, Cowan S, et al. Pim serine/ thraonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci U S A. 2002;99:2175-2180.
32. Yang J, Aittomäki S, Pesu M, et al. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J. 2002; 21;4950-4958.
33. Silva D, Wood TJ, Schindler C, Lobie PE, Norstedt G. Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma-activated sequence-like DNA elements. J Biol. Chem. 1994;269:26208-26214.
34. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 1988;7:2089-2095.
35. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991;9:2499.
36. Paukku K, Yang J, Silvennoinen O. Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5. Mol Endocrinol. 2003; 17:1805-1814.
37. Reddy EP, Korapati A, Chaturvedl P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unvelled. Oncogene. 2000;19:2532-2547.
38. Yasukawa H, Sasaki A, Yoshimure A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 2000;18:143-164.
39. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nature Rev Immunol. 2002;2:410-416.
40. Cohney SJ, Sanden D, Cacalano NA, et al. SOCS-3 is tyrosine-phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol. 1999;19:4980-4988.
41. Sporri B, Kovanen PE, Sasaki A, Yoshimura A, Leonard WJ. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood. 2001; 97:221-226.
42. Cacalano NA, Sanden D, Johnston JA. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nature Cell Biol. 2001;3:460-465.
43. Haan S, Ferguson P, Sommer U, et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J Biol Chem. 2003;278:31972-31979.
44. Hoover RR, Geriach W, Koh EY, Daley GQ. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematapoietic cells. Oncogene. 2001;20:5826-5835.
45. Scheijen B, Jonkers J, Acton D, Bems A. Characterizatilon of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and pim-1 transgenic mice. J Virol. 1997;71:9-16.
46. Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, Möröy T. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene. 1998;17:2661-2667.
47. Mikkers H, Allen J, Knipscheer P, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nature Gen. 2002;32:153-159.
48. Jegalian AG, Wu H. Regulation of Socs gene expression by the proto-oncogene GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J Biol Chem. 2002;277:2345-2352.
49. Li S, Chen S, Xu X, Sundstedt A, et al. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J Exp Med. 2000; 191:985-994.